Fig. 1From: A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional statusMean and standard error (SE) 6-min walk test (6-MWT) at baseline, 1 and 3 months in the Ferric Derisomaltose (FDI) and placebo armsBack to article page